Pharma & Biotech

Despite a steady dividend and positive clinical trial news, AbbVie's stock price has struggled to gain momentum. This creates a...

The competitive landscape for treating Stargardt disease has intensified following a significant clinical announcement. While Ocugen continues developing its novel...

Investor nerves are being tested as shares in Healwell AI exhibit extreme volatility, trading dangerously close to a pivotal support...

The shares of biotech firm Capricor Therapeutics have become a pure speculative instrument, with their fate entirely dependent on the...

The biotech sector often presents a fascinating dichotomy, and Axsome Therapeutics currently embodies it perfectly. The company is experiencing a...

As Johnson & Johnson shares trade near their annual peak, a compelling dynamic is unfolding behind the scenes. The contrasting...

A significant strategic move by Canadian biotechnology firm Bionxt Solutions could mark a pivotal moment for the company. On December...

Time is running out for investors in CureVac, the former mRNA pioneer, as a critical deadline approaches. The company's acquisition...

Having recently surpassed the historic $1 trillion market capitalization milestone, pharmaceutical titan Eli Lilly now faces pressure on its share...

The shares of Redcare Pharmacy have endured a punishing year for investors, with more than half of the company's market...